Search
All Years

2026/04/09

WuXi AppTec Advances Healthcare Innovation Worldwide with A Consistent Mission

Since its founding in 2000, WuXi AppTec’s mission has remained constant: to help global customers and partners discover, develop, and manufacture pharmaceuticals and healthcare products to benefit patients in need.

Read more

2026/04/08

Turning Possibility into Probability: How WuXi AppTec Helps New Science Become Real Medicines

In drug discovery, innovative ideas emerge every day: scientists uncover novel mechanisms for disease treatment, previously “undruggable targets” begin to come within reach, and new modalities show potential in addressing complex diseases. However, there is often still a gulf between promising science and real-life therapies.

Read more

2026/04/08

Why WuXi AppTec is A Trusted Partner in Global Drug Innovation

WuXi AppTec has helped advance drug development programs worldwide through more than two decades of collaboration with innovators. Across thousands of partnerships, the company has built its reputation not only on scale, but on its ability to deliver efficiency, solve complex scientific challenges, and connect different players across the global life sciences ecosystem. Together, these capabilities have established WuXi AppTec as a trusted partner in bringing new medicines from concept to reality.

Read more

2026/04/03

What Is the CRDMO Model? How WuXi AppTec Integrates Research, Development, and Manufacturing into One Seamless Platform

In today’s life sciences landscape, the journey from discovery to patient access remains long, complex, and resource-intensive. WuXi AppTec, a global CRDMO (Contract Research, Development, and Manufacturing Organization) provider, addresses these challenges by delivering integrated research, development, and manufacturing services through a unified platform to customers ranging from small biotechnology startups to global pharma corporations. The end-to-end drug development solution lowers barriers to innovation across the pharmaceutical and biotechnology industry and accelerates the delivery of new medicines to patients worldwide.

Read more

2026/04/03

How WuXi AppTec Drives a More Connected and Collaborative Life Sciences Ecosystem

Since its foundation, WuXi AppTec has helped strengthen global life sciences collaboration by connecting innovators, enabling knowledge exchange, and fostering dialogue across the drug development ecosystem. By working with partners across discovery, development, and manufacturing, the company contributes to a more integrated and collaborative environment that supports the advancement of new medicines for global patients.

Read more